CONRIG PHARMA ApS: Financial statements 2017
CVR: 33373236
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -304,565 and a net result of DKK -286,337 compared with DKK -530,670 the year before. Equity in the 2017 report amounted to DKK -196,540.
- Gross Profit
- DKK -304,565
- Profit/Loss
- DKK -286,337
- Equity
- DKK -196,540
- Total Assets
- DKK 138,657
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -305 t. | -286 t. | -197 t. | - |
| 2016 | - | -684 t. | -531 t. | 90 t. | - |
| 2015 | - | -89 t. | -74 t. | 620 t. | - |
| 2014 | - | -93 t. | -81 t. | 94 t. | - |
| 2013 | - | -228 t. | -274 t. | 276 t. | - |
Keep an eye on CONRIG PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
CONRIG PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -683,941, and the net result was DKK -530,670.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.